Quick Summary
Romstim 250mcg Injection
Last updated on 06 Jul 2026 | 12:11 PM (IST)
₹1734
MRP: ₹3854.06
(You Save ₹2120.06)
1 VIAL(s)
.jpg)
Romstim 250mcg Injection
Salt Composition
ROMIPLOSTIMMarketer
HETERO HEALTHCARE LTD
Prepaid Only. Non-Returnable.
55% OFF
₹1734
MRP: ₹3,854.06
Inclusive of all taxes
55% Off
Salt Composition
ROMIPLOSTIMMarketer
HETERO HEALTHCARE LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Romiset 250mcg Injection 6ml
ALKEM LABORATOR...
₹ 2468.00/injection
43% costlier
Romy 250mcg Injection
INTAS PHARMACEU...
₹ 2579.00/injection
49% costlier
Augplat 250mcg Injection
ZYDUS CADILA
₹ 2799.00/injection
62% costlier
Introduction
Romstim 250mcg Injection belongs to the platelet-stimulating agent category and contains Romiplostim. It is used to treat immune primary thrombocytopenia (ITP), a condition where the immune system mistakenly destroys platelets, leading to low platelet counts. This medicine is mostly prescribed for adults and children aged 18 years and above when other treatments have not been effective. It is recommended when immunoglobulins, corticosteroids, or splenectomy have failed to restore platelet levels. The medication is administered according to the physician’s guidance, and understanding the Romstim Injection dosage is essential, as the dosage is individualized based on platelet response and clinical need.
This drug is contraindicated in individuals with known hypersensitivity to Romiplostim or medicines produced using E. coli–based DNA technology. Before receiving this injection, inform your physician if you have liver disorders, cancer, recent surgery, smoking habits, or if you are taking birth control pills. These factors can influence treatment safety and effectiveness and help your doctor determine whether adjustments are required.
During treatment, your physician will regularly monitor blood tests to detect any abnormalities that may suggest bone marrow changes. Romiplostim has been associated with significant bone marrow alterations, so ongoing evaluation is necessary. Depending on the findings, your doctor may decide to continue or discontinue therapy. Romstim 250mcg Injection is not recommended for pregnant individuals unless specifically indicated. If you are pregnant, suspect pregnancy, or planning to conceive, inform your physician before treatment. Since it is unknown whether the drug passes into breast milk, breastfeeding should be avoided.
For patients checking affordability, the Romstim 250mcg Injection price may vary by pharmacy and location. Those seeking convenience can Romstim 250mcg Injection buy online through verified medical platforms. If Romstim is not suitable, your doctor may recommend a Romstim 250mcg Injection substitute to ensure continued management of ITP.
Uses
Romstim 250mcg Injection uses are
Treatment of immune thrombocytopenia (ITP)
How Romstim 250mcg Injection Works
Romstim 250mcg Injection works by stimulating the production of platelets in the bone marrow. It binds to and activates the thrombopoietin receptor, which promotes the development and maturation of platelets. This helps to increase the platelet count in individuals with ITP.
Interaction of Romstim 250mcg Injection with other drugs
Thiazide Diuretics (Severe)
Drugs like hydrochlorothiazide may raise blood calcium when combined with Romstim, increasing toxicity risk. Dose adjustment and monitoring are essential.Digoxin (Moderate)
High calcium levels caused by Romstim may increase the risk of digoxin toxicity. Heart rhythm and serum digoxin levels should be monitored.Magnesium-Containing Antacids (Moderate)
Romstim may enhance magnesium absorption, potentially causing electrolyte imbalance. Monitoring is advised in long-term use.Corticosteroids (Moderate)
Steroids such as prednisone may reduce the effectiveness of Romstim by interfering with calcium metabolism. Dose adjustments may be needed.Phosphate Binders (Mild)
Concurrent use may slightly alter phosphate and calcium balance. Periodic blood tests are recommended to ensure safe levels.
Storage Conditions
Store Romstim 250mcg Injection in a refrigerator (2°C - 8°C).
Do not freeze.
How to Use Romstim 250mcg Injection
Romstim 250mcg Injection will be administered to you by a healthcare professional in a hospital setting. It is usually administered as a subcutaneous injection (under the skin). Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.
Safety Advices
Pregnancy
Romstim 250mcg Injection is not recommended for pregnant patients unless specifically indicated by your doctor. Inform your physician if you are pregnant, suspecting, or planning for a pregnancy before initiating the treatment.
Breast Feeding
It is not known whether Romstim 250mcg Injection is present in human milk. Therefore, this drug is not recommended for use while breastfeeding.
Lungs
It is unknown whether Romstim 250mcg Injection is safe for patients with lung problems. Inform your physician if you have lung disease before starting the treatment.
Liver
It is unknown whether Romstim 250mcg Injection is safe for patients with liver problems. Inform your physician if you have liver disease before starting the treatment.
Alcohol
It is unknown whether consuming alcohol interacts with Romstim 250mcg Injection. Please consult your doctor for more advice.
Driving
Some side effects of Romstim 250mcg Injection may impair your ability to drive or operate machinery safely. It is advisable to discuss this with your doctor before engaging in such activities.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Romstim 250mcg Injection side effects are
Serious
Loss of response
Progression of Myelodysplastic Syndromes
Thromboembolic complications
Leukemia
Higher risk of blood clots
Common
Headache, dizziness
Allergic reaction
Upper respiratory tract infection
Joint pain, muscle pain
Indigestion
Sleeping trouble
Tingling or numbness of the feet or hands
Abdominal pain, diarrhoea, and indigestion
Fever, cough
Expert tips
Always take Romstim 250mcg Injection under medical supervision in a hospital or clinic.
Regularly monitor your platelet counts as advised to track treatment progress and safety.
Inform your doctor if you're on blood thinners, as they may increase bleeding risk.
Watch for signs of blood clots like limb pain or shortness of breath and report them immediately.
Tell your doctor about any unusual symptoms like dizziness or fatigue during treatment.
FAQs
Q1.
What precautions should be taken before using Romstim 250mcg Injection?
Before taking Romstim 250mcg Injection, it is important to inform your physician about any liver problems, history of cancer, recent surgeries, smoking habits, and the use of birth control pills. These factors may affect the safety and effectiveness of the medication, and your physician needs to be aware of them.
Q2.
What are the common side effects of Romstim 250mcg Injection?
The most common side effects of Romstim 250mcg Injection include headache and respiratory tract infections. However, side effects can vary from person to person. If you experience any concerning side effects or have any concerns, it is advisable to consult your physician.
Q3.
What is the correct method of administering Romstim 250mcg Injection?
Romstim 250mcg Injection is administered through subcutaneous injections (under the skin). Your physician will provide the specific dosing and administration instructions.
Q4.
What is the working mechanism of Romstim 250mcg Injection?
Romstim 250mcg Injection works by stimulating the production of platelets in the bone marrow. It binds to and activates the thrombopoietin receptor, promoting platelet development and maturation. This helps to increase the platelet count in individuals with ITP.
Q5.
Can Romstim 250mcg Injection be used in children?
Romstim 250mcg Injection is approved for use in adults and children aged 18 years and over with immune primary thrombocytopenia (ITP) when other treatments are ineffective. The paediatrician will determine the dosing and administration.
Fact Box
Molecule name | Romiplostim |
Therapeutic class | Platelet-stimulating agents |
Pharmacological class | Thrombopoietin receptor agonists |
Indications | Treatment of immune thrombocytopenia (ITP) |
References
Amgen Limited, Electronic medicines compendium (EMC), [ Revised on Oct 2021] [ Accessed on 14th July 2023],https://www.medicines.org.uk/emc/files/pil.567.pdf
Amgen Inc, US Food and Drug Administration, [ Revised on Dec 2018] [Accessed on 14th July 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125268s163lbl.pdf
Douglas B.cines et al.; Safety and efficacy of romiplostim in splenectomized patients with primary immune thrombocytopenia; Haematologica; Published on August 2017; Accessed on 14th July 2023; https://www.haematologica.org/article/view/8154
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
P. Thirumal Reddy
B. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 06 Jul 2026 | 12:11 PM (IST)
Want to know more?
Read Our Editorial Policy
